Evidence map›Paper›PMID 36354495›Full record

ReviewBiosensors2022

Recent Advances, Opportunities, and Challenges in Developing Nucleic Acid Integrated Wearable Biosensors for Expanding the Capabilities of Wearable Technologies in Health Monitoring.

Mohammad Janghorban, Irvyne Aradanas, Sara Kazemi, Philippa Ngaju, Richa Pandey

Abstract readReview
In one paragraph

Review in Biosensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mohammad JanghorbanDepartment of Biomedical Engineering, University of Calgary, Calgary, AB T2N 1N4, Canada.ORCID 0000-0003-4097-7265
Irvyne AradanasDepartment of Biomedical Engineering, University of Calgary, Calgary, AB T2N 1N4, Canada.ORCID 0000-0002-6547-4077
Sara KazemiDepartment of Biomedical Engineering, University of Calgary, Calgary, AB T2N 1N4, Canada.ORCID 0000-0003-2891-4886
Philippa NgajuDepartment of Biomedical Engineering, University of Calgary, Calgary, AB T2N 1N4, Canada.ORCID 0000-0002-2501-8392
Richa PandeyDepartment of Biomedical Engineering, University of Calgary, Calgary, AB T2N 1N4, Canada.ORCID 0000-0001-5070-0353

Funding

Natural Sciences and Engineering Research Council 10036632University of Calgary 10034788
6 · The paper itself

Abstract

Wearable biosensors are becoming increasingly popular due to the rise in demand for non-invasive, real-time monitoring of health and personalized medicine. Traditionally, wearable biosensors have explored protein-based enzymatic and affinity-based detection strategies. However, in the past decade, with the success of nucleic acid-based point-of-care diagnostics, a paradigm shift has been observed in integrating nucleic acid-based assays into wearable sensors, offering better stability, enhanced analytical performance, and better clinical applicability. This narrative review builds upon the current state and advances in utilizing nucleic acid-based assays, including oligonucleotides, nucleic acid, aptamers, and CRISPR-Cas, in wearable biosensing. The review also discusses the three fundamental blocks, i.e., fabrication requirements, biomolecule integration, and transduction mechanism, for creating nucleic acid integrated wearable biosensors.

Indexed as

Biosensing TechniquesNucleic AcidsWearable Electronic DevicesPoint-of-Care TestingNucleic AcidsaptamersCRISPR-Casfabricationnucleic acid assayswearable biosensors

Identifiers

PMID36354495
PMCPMC9688223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.